Lung Cancer

Quest for mesothelioma treatments centres on genomic vulnerabilities

The lack of breakthrough treatments for mesothelioma in recent years is because the cancer is not associated with a single genetic mutation that can be targeted, a UK expert told COSA 2018 in Perth. But the successful genome mapping of mesothelioma tumour cells by Australian and UK researchers has opened the door to personalised cancer ...

Already a member?

Login to keep reading.

© 2022 the limbic